Director’s Major Stock Sale at Oncology Institute!

New insider activity at Oncology Institute ( (TOI) ) has taken place on November 20, 2025.TipRanks Black Friday Sale Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off Director Mark L Pacala recently executed a significant transaction by selling 50,000 shares of Oncology Institute stock, amounting to a total value of $200,000. This move marks a notable shift in the director’s holdings within the company. Recent Updates on TOI stock The Oncology Institute, Inc. (TOI) has reported a strong financial performance in its recent Q3 earnings call, with significant revenue growth and improvements in adjusted EBITDA. The company achieved a 23% increase in revenue year-over-year, driven by a 42% surge in the Pharmacy business and a 13% growth in the fee-for-service segment. Despite challenges such as a cybersecurity incident and a one-time reserve impact, TOI raised its full-year revenue guidance to $495-505 million, reflecting confidence in its strategic initiatives. The company’s expansion efforts in Florida and the introduction of AI in operations are expected to enhance efficiency and contribute to future growth. Analysts have maintained a cautious outlook due to high leverage and negative equity, despite the positive earnings call highlights. Spark’s Take on TOI Stock According to Spark, TipRanks’ AI Analyst, TOI is a Neutral. The Oncology Institute’s overall stock score is primarily impacted by its weak financial performance and valuation challenges. Despite positive developments in revenue growth and operational improvements highlighted in the earnings call, the company’s high leverage, negative equity, and ongoing losses weigh heavily on its financial health. Technical indicators also suggest bearish momentum, further contributing to the low score. To see Spark’s full report on TOI stock, click here. More about Oncology Institute YTD Price Performance: 1027.59% Average Trading Volume: 2,111,670 Technical Sentiment Signal: Buy Current Market Cap: $321.7M